BAX — Baxter International Inc

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $23.00 Analyst target: $27.67 Upside: 20.30%

About Baxter International Inc

Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions.

See the full interactive analysis & chart →

Informational only — not investment advice.